Alvéole was founded in 2010 by three researchers from CNRS in collaboration with Quattrocento, a “creator of young innovative companies” in the life sciences field that allows academic researchers to transform their inventions into commercial products.
Alvéole’s R&D and academic partnerships
Alvéole’s research, development and industrialization experts use the latest innovations in cell imaging, chemistry and biology.
Since it was founded, Alvéole has concluded solid and sustainable academic partnerships, to become a leading player in technology. The goal of these partnerships is to push PRIMO forward, so it will become a standard tool in cellular biology. They are headed by internationally recognized experts who are PRIMO’s ambassadors.
Your needs, Our innovations
Our team’s constant concern is daily interactions, so we can always consider developments from the angle of user needs.
A large share of Alvéole’s activities target the understanding and assessment of what research teams need to improve the existing technological platform and hone fresh solutions.
Our vision
Alvéole’s goal is to make the control of living cells the future of cell biology. Since 2010 and the knowledge that the microenvironment controls cells, biology research experts have required new tools.
This is why Alvéole’s team created PRIMO, a 2D and 3D custom protein micropatterning tool for all types of substrates and cell lines, including the induced stem cells.
With this new tool, we are opening new possibilities for applications in regenerative and personalized medicine or standard testing for pharmacological molecules.